ID: ALA3765661
Chembl Id: CHEMBL3765661
PubChem CID: 137189936
Max Phase: Preclinical
Molecular Formula: C17H13FN8O
Molecular Weight: 364.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cn1ncnc1C1c2n[nH]c(=O)c3cc(F)cc(c23)NC1c1cncnc1
Standard InChI: InChI=1S/C17H13FN8O/c1-26-16(21-7-22-26)13-14(8-4-19-6-20-5-8)23-11-3-9(18)2-10-12(11)15(13)24-25-17(10)27/h2-7,13-14,23H,1H3,(H,25,27)
Standard InChI Key: SKBPZMHNLRVKRR-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 364.34 | Molecular Weight (Monoisotopic): 364.1196 | AlogP: 1.28 | #Rotatable Bonds: 2 |
| Polar Surface Area: 114.27 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 9.48 | CX Basic pKa: 1.66 | CX LogP: 0.05 | CX LogD: 0.04 |
| Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.55 | Np Likeness Score: -1.23 |
| 1. Wang B, Chu D, Feng Y, Shen Y, Aoyagi-Scharber M, Post LE.. (2016) Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent., 59 (1): [PMID:26652717] [10.1021/acs.jmedchem.5b01498] |
Source(1):
